Eliminating residual iPS cells for safety in clinical application
Crossref DOI link: https://doi.org/10.1007/s13238-015-0170-4
Published Online: 2015-06-04
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Masuda, Shigeo
Miyagawa, Shigeru
Fukushima, Satsuki
Sougawa, Nagako
Okimoto, Kaori
Tada, Chika
Saito, Atsuhiro
Sawa, Yoshiki
License valid from 2015-06-04